Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott
| Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott |
| Autore | Wiviott Stephen D. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 |
| Descrizione fisica | 1 online resource (311 p.) |
| Disciplina |
616.12306
616.123061 |
| Altri autori (Persone) | WiviottStephen D |
| Collana | American Heart Association Clinical Series |
| Soggetto topico |
Coronary heart disease - Chemotherapy
Blood platelets - Aggregation Coronary heart disease - drug therapy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-4443-0333-3
1-4443-0334-1 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents
7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases PART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table |
| Record Nr. | UNINA-9910146114903321 |
Wiviott Stephen D.
|
||
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott
| Antiplatelet therapy in ischemic heart disease / / Stephen D. Wiviott |
| Autore | Wiviott Stephen D. |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 |
| Descrizione fisica | 1 online resource (311 p.) |
| Disciplina |
616.12306
616.123061 |
| Altri autori (Persone) | WiviottStephen D |
| Collana | American Heart Association Clinical Series |
| Soggetto topico |
Coronary heart disease - Chemotherapy
Blood platelets - Aggregation Coronary heart disease - drug therapy |
| ISBN |
1-4443-0333-3
1-4443-0334-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Preface; Foreword; PART I: Concepts in Platelet Physiology, Function, and Measurement; 1 Platelet physiology and the role of the platelet in ischemic heart disease; 2 Laboratory assessment of platelet function and the effects of antiplatelet agents; PART II: Pharmacology of Oral Antiplatelet Agents; 3 Cyclooxygenase inhibitors; 4 Aspirin response variability and resistance; 5 P2Y[sub(12)] inhibitors: Thienopyridines and direct oral inhibitors; 6 Thienopyridine response variability and resistance; PART III: Pharmacology of Intravenous Antiplatelet Agents
7 Pharmacology of intravenous glycoprotein IIb/IIIa antagonists8 Intravenous P2Y[sub(12)] inhibitors; 9 Antiplatelet effects of thrombin inhibitors and fibrinolytic agents; PART IV: Clinical Use of Antiplatelet Agents in Cardiovascular Disease; 10 Antiplatelet therapy in acute coronary syndrome without ST elevation; 11 Antiplatelet therapy in ST-elevation myocardial infarction; 12 Antiplatelet therapy in chronic coronary artery disease; 13 Antiplatelet therapy in peripheral arterial disease; 14 Clinical use of antiplatelet agents in cardiovascular disease: cerebrovascular diseases PART V: Special Circumstances15 Antiplatelet therapy and coronary bypass surgery: risks and benefits; 16 Management of antiplatelet therapy for non-cardiac surgery; 17 Antiplatelet therapy and coronary stents; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; R; S; T; U; V; W; Author Disclosure Table |
| Record Nr. | UNINA-9910830371803321 |
|
Wiviott Stephen D.
|
||
| Hoboken, New Jersey : , : Wiley-Blackwell, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||